What's Next in Myeloma: Trispecifics, Sequencing, and Precision Targeting

(MedPage Today) — The American Society of Clinical Oncology (ASCO) meeting featured major updates in multiple myeloma, including early data on trispecific antibodies and novel bispecific combinations, but the future of treatment will depend on…

Source link : https://www.medpagetoday.com/meetingcoverage/ascofuturefocusmm/116113

Author :

Publish date : 2025-06-17 15:29:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

What’s Next in Myeloma: Trispecifics, Sequencing, and Precision Targeting

Helgoland: Searching for the past and future of quantum physics on a tiny island

The surprisingly big impact the small intestine has on your health

Related Posts

ADHD drugs have wider life benefits, study suggests

Early ADHD Treatment Tied to Less Risk of Crime, Car Accidents

Quitting Smoking Tied to Better Odds of Recovery From Other Addictions

‘Makes No Sense’: Experts Push Back On RFK Jr.’s Doubts About Hepatitis B Vaccine

No Chemo Benefit in Older Women With High-Risk HR-Positive Breast Cancer

GLP-1 Drugs May Hold Benefit in Painful Skin Disease

ADHD drugs have wider life benefits, study suggests

Early ADHD Treatment Tied to Less Risk of Crime, Car Accidents

Quitting Smoking Tied to Better Odds of Recovery From Other Addictions

‘Makes No Sense’: Experts Push Back On RFK Jr.’s Doubts About Hepatitis B Vaccine

No Chemo Benefit in Older Women With High-Risk HR-Positive Breast Cancer

GLP-1 Drugs May Hold Benefit in Painful Skin Disease

Want to Make America Healthy? Dump RFK Jr., New Public Health Group Says

Early Treatment Shows Benefit in Infants With Presymptomatic Genetic Disease

Categories

Archives